NO943909L - Laktam-dipeptider som har HLE-inhiberende aktivitet - Google Patents

Laktam-dipeptider som har HLE-inhiberende aktivitet

Info

Publication number
NO943909L
NO943909L NO943909A NO943909A NO943909L NO 943909 L NO943909 L NO 943909L NO 943909 A NO943909 A NO 943909A NO 943909 A NO943909 A NO 943909A NO 943909 L NO943909 L NO 943909L
Authority
NO
Norway
Prior art keywords
heterocyclic compounds
hle
dipeptides
lactam
inhibitory activity
Prior art date
Application number
NO943909A
Other languages
English (en)
Other versions
NO943909D0 (no
Inventor
Peter Robert Bernstein
Royston Martin Thomas
Peter Warner
Donald John Wolanin
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929208379A external-priority patent/GB9208379D0/en
Priority claimed from GB929208380A external-priority patent/GB9208380D0/en
Priority claimed from GB929214448A external-priority patent/GB9214448D0/en
Priority claimed from GB929217363A external-priority patent/GB9217363D0/en
Priority claimed from GB929217364A external-priority patent/GB9217364D0/en
Priority claimed from GB929217362A external-priority patent/GB9217362D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO943909L publication Critical patent/NO943909L/no
Publication of NO943909D0 publication Critical patent/NO943909D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse vedrører Visse nye hetero- cykliske forbindelser, som er 1-pyridylacetamid-forbindelser med formel (I) CF, som er inhibitorer av human leukocytt-elastase (HLE), også kjent som human neutrofil elastasé (HNE), som gjør dem nyttige når slik inhibering er ønsket, f.eks. som forskningsredskap ved farmakologiske, diagnostiske og beslektede undersøkelser og ved behandling av slike sykdommer hos pattedyr hvor HLE spiller en rolle. Oppfinnelsen inkluderer også mellomprodukter egnet ved syntese av disse heterocykliske forbindelsene, fremgangsmåter for fremstilling av de heterocykliske for- bindelsene, farmasøytiske preparater som inneholder slike heterocykliske forbindelser og fremgangsmåter for deres anvendelse.
NO943909A 1992-04-16 1994-10-14 Laktam-dipeptider som har HLE-inhiberende aktivitet NO943909D0 (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB929208379A GB9208379D0 (en) 1992-04-16 1992-04-16 Heterocyclic amines
GB929208380A GB9208380D0 (en) 1992-04-16 1992-04-16 Heterocyclic compounds
GB929214448A GB9214448D0 (en) 1992-07-08 1992-07-08 Heterocyclic agents
GB929217363A GB9217363D0 (en) 1992-08-14 1992-08-14 Heterocyclic amines
GB929217364A GB9217364D0 (en) 1992-08-14 1992-08-14 Heterocyclic agents
GB929217362A GB9217362D0 (en) 1992-08-14 1992-08-14 Heterocyclic compounds
PCT/GB1993/000794 WO1993021212A1 (en) 1992-04-16 1993-04-15 Lactam dipeptides having hle inhibiting activity

Publications (2)

Publication Number Publication Date
NO943909L true NO943909L (no) 1994-10-14
NO943909D0 NO943909D0 (no) 1994-10-14

Family

ID=27547161

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943909A NO943909D0 (no) 1992-04-16 1994-10-14 Laktam-dipeptider som har HLE-inhiberende aktivitet

Country Status (13)

Country Link
EP (1) EP0630382B1 (no)
JP (1) JPH07505873A (no)
AT (1) ATE149175T1 (no)
AU (1) AU4076993A (no)
CA (1) CA2132543A1 (no)
DE (1) DE69308291T2 (no)
FI (1) FI944802A0 (no)
GB (1) GB9307555D0 (no)
HU (1) HUT70430A (no)
IL (1) IL105424A0 (no)
MX (1) MX9302215A (no)
NO (1) NO943909D0 (no)
WO (1) WO1993021212A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US20020119985A1 (en) 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
EP0826671B1 (en) * 1995-04-27 2004-12-29 Mitsubishi Pharma Corporation Heterocyclic amide compounds and medicinal use of the same
CN1247542A (zh) * 1996-12-06 2000-03-15 康泰驰公司 丝氨酸蛋白酶抑制剂
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
WO2000032216A1 (en) 1998-06-03 2000-06-08 Cortech Inc. Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
KR20040038909A (ko) 2001-07-30 2004-05-08 산꼬 가가꾸 고교 가부시끼가이샤 제전성 조성물 및 그 제조방법
IL163453A0 (en) 2004-08-10 2009-02-11 Yeda Res & Dev Enzyme inhibitor in leukemia
WO2010126914A1 (en) * 2009-04-27 2010-11-04 Elan Pharmaceuticals, Inc. Pyridinone antagonists of alpha-4 integrins
JP7672641B2 (ja) 2019-09-17 2025-05-08 メレオ バイオファーマ ４ リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
IL297211B2 (en) 2020-04-16 2025-12-01 Mereo Biopharma 4 Ltd Methods involving neutrophil elastase inhibitor alvelestat for treating respiratory disease mediated by alpha-1 antitrypsin deficiency
KR20240090272A (ko) 2021-10-20 2024-06-21 메레오 바이오파마 4 리미티드 섬유화 치료에 사용하기 위한 호중구 엘라스테이스 억제제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
GB9207145D0 (en) * 1991-04-18 1992-05-13 Ici Plc Heterocyclic amides

Also Published As

Publication number Publication date
HU9402968D0 (en) 1995-02-28
AU4076993A (en) 1993-11-18
WO1993021212A1 (en) 1993-10-28
GB9307555D0 (en) 1993-06-02
MX9302215A (es) 1993-10-01
HUT70430A (en) 1995-10-30
ATE149175T1 (de) 1997-03-15
IL105424A0 (en) 1993-08-18
FI944802A7 (fi) 1994-10-12
FI944802L (fi) 1994-10-12
EP0630382B1 (en) 1997-02-26
JPH07505873A (ja) 1995-06-29
DE69308291D1 (de) 1997-04-03
CA2132543A1 (en) 1993-10-28
DE69308291T2 (de) 1997-06-26
FI944802A0 (fi) 1994-10-12
EP0630382A1 (en) 1994-12-28
NO943909D0 (no) 1994-10-14

Similar Documents

Publication Publication Date Title
NO943911L (no) Pyrimidinyl-acetamider som elastaseinhibitorer
NO943909L (no) Laktam-dipeptider som har HLE-inhiberende aktivitet
NO943910L (no) Laktam-peptider med HLE-hemmende virkning
CA2076226A1 (en) Substituted 1-pyrimidinylacetamide compounds
TW262475B (en) Heterocyclic amides, intermediates and process for their preparation and pharmaceutical compositions containing them
AU3959693A (en) Alpha-aminoboronic acid peptides and their use as elastase inhibitors
NO972261L (no) Hypolipidemiske benzodiazepiner
FI946202A0 (fi) Fluoria sisältäviä dipeptidejä inhibiittoreina ihmisen lenkosyyttielastaasi-inhibiittoreita vastaan
ATE157099T1 (de) Laktam-dipeptide mit inhibierender wirkung auf die menschliche leukozytenelastase
DK0397427T3 (da) Fluoramidderivater med human leukocytelastase-inhiberende aktivitet
DK0399688T3 (da) Trifluorketopeptidderivater, som er nyttige som human leukocyt-elastaseinhibitorer
NO944659L (no) Laktam-dipeptider med HLE-inhiberende aktivitet
NO945091L (no) Fluorholdige dipeptider som inhibitorer mot menneske-leukocyt-elastase-inhibitorer